Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | AMY1A | P0DUB6 | 12/20 | 0.40 |
| ▸ | PDE5A | O76074 | 1/20 | 0.38 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.38 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.38 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.36 |
| ▸ | PDE2A | O00408 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10551908 | 0.88 | AMY1A (0.39) | KDM4ECYP1A2CYP3A4AMY1APDE5A | |
| SCHEMBL9703649 | 0.83 | AMY1A (0.43) | AMY1APDE5APDE3BPDE3APDE2A | |
| SCHEMBL9704494 | 0.82 | CDK4 (0.47) | KDM4ECYP1A2CYP3A4AMY1APDE5A | |
| SCHEMBL9702924 | 0.80 | AMY1A (0.41) | KDM4ECYP1A2AMY1APDE5APDE3B | |
| SCHEMBL10852513 | 0.80 | AMY1A (0.40) | KDM4ECYP1A2AMY1APDE5APDE3B | |
| SCHEMBL9704539 | 0.79 | AMY1A (0.40) | AMY1APDE5APDE3BPDE3A | |
| SCHEMBL10373752 | 0.78 | PDE3B (0.48) | KDM4ECYP1A2AMY1APDE5APDE3B | |
| SCHEMBL9704436 | 0.77 | PDE5A (0.43) | KDM4ECYP1A2AMY1APDE5APDE3B | |
| SCHEMBL9703428 | 0.77 | PDE3B (0.41) | KDM4ECYP1A2AMY1APDE5APDE3B | |
| SCHEMBL10742305 | 0.77 | PDE5A (0.47) | KDM4ECYP1A2AMY1APDE5APDE3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5116843-A | Anticoagulants, hypotensive agents and cardiovascular disorder | BOEHRINGER MANNHEIM GMBH (DE) | 1992-05-26 | — | — | US | disclosed |